STAND. COM. REP. NO. 1182

 

Honolulu, Hawaii

, 2019

 

RE: H.B. No. 700

H.D. 2

 

 

 

 

Honorable Scott K. Saiki

Speaker, House of Representatives

Thirtieth State Legislature

Regular Session of 2019

State of Hawaii

 

Sir:

 

Your Committee on Judiciary, to which was referred H.B. No. 700, H.D. 1, entitled:

 

"A BILL FOR AN ACT RELATING TO PHARMACISTS PRESCRIBING AND DISPENSING OF OPIOID ANTAGONIST,"

 

begs leave to report as follows:

 

The purpose of this measure is to clarify that an opioid antagonist may be prescribed and dispensed in both the name of an individual who is at risk for an opioid overdose, or in the name of a family member or caregiver of an at-risk individual who is requesting the opioid antagonist.

 

The Department of Health, University of Hawaii at Hilo Daniel K. Inouye College of Pharmacy, Kaiser Permanente Hawaii, Walgreen Co., Drug Policy Forum of Hawaii, and Oahu County Committee on Legislative Priorities of the Democratic Party of Hawaii testified in support of this measure. The Board of Pharmacy, Hawaii Medical Service Association, and an individual provided comments.

 

Your Committee has amended this measure by:

 

(1) Adding a requirement of good faith and reasonable care from a pharmacist while prescribing or dispensing an opioid antagonist; and

(2) Changing its effective date to upon approval, and adding a sunset date of June 30, 2024.

 

As affirmed by the record of votes of the members of your Committee on Judiciary that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 700, H.D. 1, as amended herein, and recommends that it pass Third Reading in the form attached hereto as H.B. No. 700, H.D. 2.

 

Respectfully submitted on behalf of the members of the Committee on Judiciary,

 

 

 

 

____________________________

CHRIS LEE, Chair